BASF and Dyadic International have entered into a non-exclusive worldwide research and license agreement. As per the terms of the agreement, BASF will use Dyadic's patented and proprietary C1 platform technology to develop, manufacture, ...
The European Community's Seventh Framework Program has granted funds to Dyadic International's research and development center in the Netherlands, a member of the Bio-Mimetic Project, to develop enzymes. As part of the Bio-Mimetic ...
Tags: Bio-Mimetic Project, C1 platform technology, modify lignin
JUPITER, Fla., - Dyadic International, Inc. (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical ...
Tags: U.S.Patent, Dyadic International